Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Nucleic acid aptamers and their complimentary antidotes: Entering an era of antithrombotic pharmacobiologic therapy

  • Duke University
  • Duke Translational Research Institute
  • Boston University
  • Regado Biosciences

Producción científica › revisión exhaustiva

9 Citas (Scopus)

Resumen

The translation of fundamental science-based constructs to the preemptive identification and optimal management of individuals with or those at risk for thrombotic disorders of the cardiovascular system has taken a step closer to being realized with the development of molecular technologies that include nucleic acid aptamers and their complimentary oligonucleotide antidotes. Herein, we summarize our experience with factor IX and von Willebrand factor aptamers, and introduce the era of antithrombotic pharmacobiologic therapy.

Idioma originalEnglish
Páginas (desde-hasta)378-382
Número de páginas5
PublicaciónHamostaseologie
Volumen27
N.º5
EstadoPublished - 2007
Publicado de forma externaSí

Huella

Profundice en los temas de investigación de 'Nucleic acid aptamers and their complimentary antidotes: Entering an era of antithrombotic pharmacobiologic therapy'. En conjunto forman una huella única.

Citar esto